...
首页> 外文期刊>Radiation Oncology Journal >Effect of Tumor Hypoxia on Efficacy of Tirapazamine Combined with Fractionated Irradiation in Mouse Tumor
【24h】

Effect of Tumor Hypoxia on Efficacy of Tirapazamine Combined with Fractionated Irradiation in Mouse Tumor

机译:肿瘤缺氧对替拉帕明联合分次照射对小鼠肿瘤疗效的影响

获取原文
           

摘要

PURPOSE: Tumor hypoxia can be overcome with hypoxic cytotoxin. In mouse tumor, tirapazamine's efficacy of the potentiating radiation effect was tested by the tumor oxygenation status combined with hyperfactionated radiotherapy. MATERIALS AND METHODS: The control and hypoxic mouse tumors were established by inoculation of RIF-1 tumor cells into the normal or previously irradiated back and thigh of C3H mice. When the tumors reached a proper size, both the control and hypoxic tumors were given hyperfractionated treatments (8 fractions/4 days) with saline (0.02 ml/g), tirapazamin (0.08 mM/0.02 ml/kg), irradiation (2.5 Gy), irradiation combined with tirapazamine given 30 minutes prior to each irradiation. The response was evaluated by the growth delay assay by measuring tumor size from day 0 (12 hrs prior to the first fractionation) to the day when the volume had 4-fold increase or cross sectional area had 2-fold increase. RESULTS: Overall growth pattern showed that tirapazamine potentiated radiation effect in back and thigh tumors grew in the normal and preirradiated tumor bed. With growth delay assay using reference point of initial tumor volume or cross sectional area, tirapazamine potentiated radiation effect 1.9 times for the control and 2.4 times for the hypoxic tumors in back, and 1.85 times for the control and 1.6 times for the hypoxic tumors. With reference of 4-fold increase of the initial volume or 2-fold increase of the cross sectional area, tirapazamine potentiated radiation effect 1.48 times for the control and 2.02 times for the hypxic tumors in back, and 1.85 times for the control and 1.6 times for the hypoxic tumors. CONCLUSION: Present result indicated that radiation response of hypoxic tumors was potentiated by tirapazamine in the back or thigh tumors grew in the control or preirradiated tumor bed, and potentiation of the hypoxic tumors was equal to or greater than that of the control tumors in the back or thigh.
机译:目的:低氧细胞毒素可以克服肿瘤的缺氧。在小鼠肿瘤中,通过肿瘤氧合作用和过度放疗联合检测了替拉帕明增强放射作用的功效。材料与方法:通过将RIF-1肿瘤细胞接种到C3H小鼠的正常或先前辐射过的背部和大腿中来建立对照小鼠和低氧小鼠肿瘤。当肿瘤达到适当大小时,对照和缺氧肿瘤均接受超分次治疗(8次/ 4天),分别使用盐水(0.02 ml / g),提拉帕明(0.08 mM / 0.02 ml / kg),放射线(2.5 Gy)治疗,在每次照射前30分钟给予辐射和替拉帕明。通过生长延迟测定法,通过测量从第0天(第一次分级分离前12小时)到体积增加4倍或横截面积增加2倍的一天的肿瘤大小来评估反应。结果:总体生长模式显示,替拉帕明增强的对背部和大腿肿瘤的放射作用在正常和预辐照的肿瘤床层均有。通过使用初始肿瘤体积或横截面积的参考点进行生长延迟测定,替拉帕明增强的放射效应是对照组的1.9倍,背部缺氧肿瘤的2.4倍,对照组的1.85倍,缺氧肿瘤的1.6倍。参照初始体积的4倍增加或横截面积的2倍增加,替拉帕明增强的辐射效应是对照组的1.48倍,背部的催乳性肿瘤的2.02倍,对照组的1.85倍和1.6倍用于缺氧性肿瘤。结论:目前的结果表明,替拉帕明增强了缺氧性肿瘤的放射反应,在对照或预辐照的肿瘤床中生长的背部或大腿肿瘤,缺氧性肿瘤的增强作用等于或大于对照中的对照肿瘤。或大腿。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号